Apex Capital & Finance FY26 Results: Net profit rises 7x to ₹3.73 crore
- Net profit surged 709% YoY to ₹3.73 crore in FY26
- Revenue jumped 157% to ₹7.13 crore driven by interest income
- Expenses remained stable at ₹2.15 crore despite revenue growth
- Company raised ₹23.75 crore via convertible share warrants
- No dividend declared; AGM scheduled for September 28, 2026

*this image is generated using AI for illustrative purposes only.
Apex Capital & Finance posted a net profit of ₹3.73 crore for the financial year ended March 31, 2026, a sharp increase from ₹0.53 crore in the previous year. Total revenue climbed 157% year-on-year to ₹7.13 crore, supported by robust interest income growth.
The non-deposit accepting non-banking finance company (NBFC) generated ₹7.13 crore in operating income, up from ₹2.78 crore in FY25. This surge in top-line performance significantly outpaced the rise in total expenses, which increased marginally to ₹2.15 crore from ₹1.98 crore. Consequently, profit before tax expanded to ₹4.98 crore against ₹0.80 crore previously.
Financial Performance
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue | ₹7.13 crore | ₹2.78 crore | +157% |
| Net Profit | ₹3.73 crore | ₹0.53 crore | +709% |
| Employee Costs | ₹1.26 crore | ₹0.98 crore | +29% |
| Admin Expenses | ₹0.87 crore | ₹0.86 crore | +1% |
Operating leverage was evident as employee benefit expenses rose by 29% while administrative and other expenses remained nearly flat. The absence of finance costs in FY26, compared to ₹0.13 crore in FY25, further aided bottom-line expansion.
What the Numbers Show
The profitability surge was driven by operational efficiency rather than cost inflation. While revenue more than doubled, total expenses grew by less than 10%. Additionally, the company transferred ₹0.75 crore (20% of net profit) to its statutory reserve as mandated by RBI guidelines, reflecting compliance with regulatory capital requirements.
Capital Raise and Governance
During the year, the company received ₹23.75 crore as the third instalment against convertible share warrants issued at ₹125 per warrant. This capital injection is recorded under 'Money Received against Share Warrants' on the balance sheet. The Board did not recommend any dividend for FY26, opting to conserve resources for future growth.
The 41st Annual General Meeting will be held on September 28, 2026, via video conferencing. Key agenda items include the reappointment of Director Sandeep Kumar and the appointment of M/s MANV & Associates as statutory auditors for five years.
Historical Stock Returns for Apex Capital & Finance
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
How will the conversion of the remaining share warrants impact Apex Capital's equity structure and potential dilution for existing shareholders?
Given the absence of finance costs in FY26, what is the company's strategy for funding future asset growth without relying on external debt?
What specific initiatives or market segments are driving the 157% revenue surge, and are these growth drivers sustainable in the current interest rate environment?


































